Skip to content

Physiologic and Nonphysiologic Sinus Rhythm

Chapter 254 | Part 6: Disorders of the Cardiovascular System

KEY CLINICAL POINTS

  • Sinus tachycardia is the most common supraventricular tachycardia (SVT), typically caused by physiologic stress (exercise, fever) or pathologic conditions (hypovolemia, hyperthyroidism).
  • Inappropriate sinus tachycardia (IST) is a nonphysiologic condition characterized by excessive sinus rate at rest or with minimal stress, often linked to autonomic dysregulation.
  • Sinus arrhythmia is a normal variant with irregular P-P intervals (<120 ms) and P-wave morphology changes, commonly respirophasic and resolved with exertion.
  • Postural orthostatic tachycardia syndrome (POTS) presents with symptomatic sinus tachycardia upon standing, often associated with autonomic dysfunction.
  • Management prioritizes addressing reversible causes (e.g., anemia, thyroid dysfunction) and may include beta-blockers, ivabradine, or catheter ablation for refractory cases.

1. DEFINITION & OVERVIEW

Sinus rhythm originates from the sinus node, with normal rate 60–100 bpm. Physiologic sinus tachycardia is an appropriate response to stress, while nonphysiologic tachycardia (e.g., IST) lacks clear triggers. Sinus arrhythmia refers to irregular P-P intervals with normal P-wave morphology.

TABLE 254-1 Common Causes of Sinus Tachycardia

Category Causes
Physiologic Causes Emotion, physical exercise, sexual intercourse, pain, pregnancy
Pathologic Causes Anxiety, panic attack, anemia, fever, dehydration, infection, malignancies, hyperthyroidism, hypoglycemia, pheochromocytoma, Cushing’s disease, diabetes mellitus with autonomic dysfunction, pulmonary embolus, myocardial infarction, pericarditis, valve disease, decompensated heart failure, shock, alcohol withdrawal
Drugs Epinephrine, norepinephrine, dopamine, dobutamine, atropine, b-adrenergic agonists (salbutamol), methylxanthines, doxorubicin, daunorubicin, beta blocker withdrawal, caffeine, alcohol
Illicit Drugs Amphetamines, cocaine, lysergic acid diethylamide, psilocybin, ecstasy

1.1 Sinus Tachycardia

Defined as sinus rate >100 bpm. Physiologic causes include exercise, anxiety, or fever; nonphysiologic causes include IST, POTS, or autonomic dysfunction. Differentiation requires ECG analysis and clinical context.

1.2 Sinus Arrhythmia

Normal variant with irregular P-P intervals (<120 ms). Respirophasic (breath-related), ventriculophasic (ventricular activity-related), or nonphasic (unrelated to cardiac/respiratory cycles). Asymptomatic and not pathogenic.

2. EPIDEMIOLOGY

Physiologic sinus tachycardia is common in healthy individuals. IST is rare, predominantly affecting women aged 30–50 years. POTS is more prevalent in young women, often post-viral or post-COVID-19. Long COVID may present with POTS-like autonomic dysfunction.

2.1 Demographics

IST: Women in third/fourth decade of life. POTS: Young women with autonomic dysfunction. Long COVID: POTS-like symptoms in post-viral patients.

2.2 Risk Factors

Autonomic dysregulation, viral infections (e.g., post-COVID-19), anxiety disorders, and medications (e.g., stimulants).

3. ETIOLOGY & PATHOPHYSIOLOGY

Physiologic tachycardia results from sympathetic stimulation or vagal withdrawal. IST involves autonomic imbalance, altered sinus node automaticity, or parasympathetic overactivity. POTS is linked to dysautonomia with impaired baroreflex sensitivity.

3.1 Mechanisms

Sympathetic activation, vagal withdrawal, or intrinsic sinus node dysfunction. IST may involve sympathetic overdrive or impaired parasympathetic modulation.

3.2 Anatomical Correlates

Sinus node located at crista terminalis (junction of right atrium and SVC). P-wave morphology reflects right atrial activation patterns.

4. CLINICAL FEATURES

Symptoms include palpitations, fatigue, dizziness, chest pain, and syncope. Physiologic tachycardia is asymptomatic or associated with exertion. IST presents with disabling palpitations without clear triggers. POTS features include orthostatic intolerance and excessive heart rate increase upon standing.

4.1 Symptomatology

Palpitations, fatigue, dizziness, syncope, chest discomfort, headaches, gastrointestinal upset. POTS: Orthostatic symptoms with >30 bpm increase within 10 min of standing.

4.2 ECG Findings

Normal sinus rhythm with P-wave morphology in leads II, III, aVF (positive), aVR (biphasic), and V1 (initially positive). IST shows irregular P-P intervals with no premature beats.

5. DIFFERENTIAL DIAGNOSIS

Focal atrial tachycardia (near sinus node), atrial flutter/fibrillation, ventricular tachycardia, and sinus node reentry. Differentiate based on P-wave morphology, rate variability, and response to vagal maneuvers.

5.1 Key Differentiators

Physiologic tachycardia: Gradual rate increase with exertion. IST: Abrupt onset without clear trigger. POTS: Orthostatic symptoms with tachycardia. Focal tachycardia: Fixed P-wave morphology.

6. INVESTIGATIONS & DIAGNOSIS

12-lead ECG to assess P-wave morphology and rate. Telemetry for intermittent episodes. Exclude structural causes (e.g., pulmonary embolism) and evaluate for autonomic dysfunction (e.g., tilt-table testing for POTS).

6.1 Diagnostic Criteria

Normal sinus rhythm with P-wave morphology in leads II, III, aVF (positive), aVR (biphasic), and V1 (initially positive). IST: Irregular P-P intervals without premature beats. POTS: >30 bpm increase within 10 min of standing without hypotension.

6.2 Algorithms

  1. Rule out reversible causes (e.g., anemia, thyroid disease). 2. Assess for POTS with orthostatic testing. 3. Evaluate for IST with prolonged ECG monitoring. 4. Consider electrophysiology study for refractory cases.

7. MANAGEMENT & TREATMENT

Treat underlying causes (e.g., infection, anemia). Beta-blockers (e.g., metoprolol), ivabradine, or clonidine for IST. POTS: Salt supplementation, fludrocortisone, midodrine, compression stockings. Catheter ablation may be considered for refractory cases.

7.1 Pharmacologic Therapy

Beta-blockers (first-line), ivabradine, clonidine, serotonin reuptake inhibitors. Avoid non-selective beta-blockers in asthma/pulmonary disease.

7.2 Non-Pharmacologic Interventions

Postural training, compression stockings, fluid/salt intake, and exercise for POTS. Avoid caffeine/alcohol in IST.

7.3 Surgical Options

Sinus node ablation for refractory IST, though long-term success is limited. May require permanent pacing for chronotropic incompetence.

8. PROGNOSIS & COMPLICATIONS

Physiologic tachycardia is benign. IST may progress to chronic tachycardia with symptoms. POTS often resolves within 3–12 months. Complications include syncope, heart failure, and chronic fatigue.

8.1 Long-Term Outcomes

IST: Variable; some patients require pacing. POTS: Spontaneous resolution in 3–12 months. Long COVID: POTS-like symptoms may persist.

9. SPECIAL CONSIDERATIONS

POTS and long COVID may present with autonomic dysfunction. Pregnancy-related tachycardia is physiologic. Avoid beta-blockers in asthma/pulmonary disease. Monitor for chronic tachycardia in elderly patients.

9.1 Pregnancy

Physiologic tachycardia is common; avoid medications with fetal risk.

9.2 Long COVID

POTS-like symptoms may persist; manage with autonomic support.

10. KEY POINTS & CLINICAL PEARLS

  • Differentiate physiologic tachycardia (gradual, exertion-related) from IST (abrupt, no trigger).
  • Rule out pulmonary embolism in acute tachycardia.
  • POTS requires orthostatic testing and autonomic support.
  • IST management includes beta-blockers, ivabradine, and ablation.
  • Asymptomatic sinus arrhythmia is normal; PACs may mimic arrhythmia.